Abstract:Yihui Guo, 1, 2 Xue Ding, 1, 2 Sheng Wang, 1, 2 Fei Wang, 1, 2 Zhongyi Zheng, 1, 2 Lifeng Zou 1, 2 1 Department of Anesthesiology, The People's Hospital of Pizhou, Xuzhou, Jiangsu, People's Republic of China; 2 Department of Anesthesiology, Pizhou Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China Correspondence: Lifeng Zou, Department of Anesthesiology, The People's Hospital of Pizhou, Pizhou Hospital affiliated to Xuzhou Medical University, 93 Renmin South Road, Pizhou, Xuzhou, Jiangsu, People's Republic of China, Tel +8615380118786, Fax +86-25-86239959, Email Purpose: High rate of cesarean section (CS) bring challenges to analgesic management after CS. Previous studies state that adjuvant treatment with a low dose of esketamine intraoperatively could reduce postoperative pain and opioid consumption, and even prevent postpartum depression. However, few researches involve in patient-controlled intravenous analgesia (PCIA) with esketamine after CS. In this trial, we explored a new combination of esketamine with tramadol for PCIA after CS with the aim to provide a better analgesic regimen for use in the clinic. Patients and Methods: 170 puerperae undergoing CS were recruited for this trial and randomly assigned into 2 groups (1:1): The control group received a formula of PCIA with butorphanol 0.1mg/kg and tramadol 400mg postoperatively, while the intervention group received a formula of PCIA with esketamine 1mg/kg and tramadol 400mg. The primary outcome was the mean numerical rating scale (NRS) scores at rest, sitting, and uterine contraction at 6 hours postoperatively. The second outcomes included the mean NRS scores at rest, sitting, and uterine contraction at 12, 24, and 48 hours postoperatively. The incidence of adverse events, postoperative sedation, postoperative sleep quality, maternal satisfaction regarding postoperative analgesia and the Edinburgh postnatal depression scale (EPDS) score were also be evaluated. Results: The mean (SD) of the mean NRS scores at rest, sitting, and during uterine contraction at 6 hours postoperatively were 4.8 (0.7) points in the intervention group and 5.3 (0.5) points in the control group. The estimated mean difference between the two groups at 6 hours postoperatively was − 0.5 points (95% confidence interval [CI], − 0.7 to − 0.3; P < 0.001). Compared with the control group, the patients in the intervention group had a significantly lower mean pain intensity at 12 and 24 hours postoperatively (− 0.5 points [95% CI, − 0.6 to − 0.3]; P < 0.001 and − 0.2 points [95% CI, − 0.4 to 0]; P = 0.019 respectively). Otherwise, differences at 48 hours after surgery between the two groups were nonsignificant (0 points [95% CI, − 0.2 to 0.2]; P = 0.802). The incidence of adverse events in the intervention group (11.8%) was significantly lower than in the control group (24.7%) (ratio difference − 12.9, [95% CI, − 24.3 to − 1.5]; P = 0.029). No difference was found in postoperative sleep quality ( P = 0.765), analgesic satisfaction ( P = 0.818) and EPDS scores ( P = 0.154) between the two groups. Conclusion: In this trial, among patients undergoing CS, esketamine combined with tramadol by PCIA improved pain intensity 6 hours postoperatively compared with butorphanol combined with tramadol. Plain Language Summary: Pain management after cesarean section is a clinical issue worthy of concern. Good postoperative pain management can reduce maternal fear of surgery and promote early postoperative breastfeeding and getting out of bed. Strong opioids are widely used for postoperative analgesia, but their many intolerable side effects plague mothers and medical staff. Esketamine, an anesthetic with powerful analgesic effects, has also been approved in recent years for treatment-resistant depression. In this current study, we used esketamine with weak opioid tramadol for patient-controlled intravenous analgesia after cesarean section. We found that, compared to traditional analgesic formulations (butorphanol combined with tramadol), esketamine combined with tramadol significantly improved early postoperative pain and reduced opioid-related adverse events. At the same time, esketamine used in patient-controlled intravenous analgesia after cesarean section did not increase central nervous system adverse reactions such as hallucinations. Our findings provide a new strategy for post-operative analgesia after cesarean section and we believe that this strategy will be beneficial for cesarean patients. Keywords: esketamine, postoperativ -Abstract Truncated-

Low-dose esketamine with sufentanil for postcesarean analgesia in women with gestational diabetes mellitus: a prospective, randomized, double-blind study

Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery

Comparison of Dural Puncture Epidural, Epidural and Combined Spinal-Epidural Anesthesia for Cesarean Delivery: A Randomized Controlled Trial.

ED 50 and ED 95 of intrathecal bupivacaine coadministered with sufentanil for cesarean delivery under combined spinal-epidural in severely preeclamptic patients.

Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial.

Postoperative Analgesic Effects Of Different Doses Of Epidural Hydromorphone Coadministered With Ropivacaine After Cesarean Section: A Randomized Controlled Trial

A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia–Induced Hypotension During Cesarean Delivery

Exploring the Analgesic Efficacy and mechanisms of low-dose esketamine in pregnant women undergoing cesarean section: A randomized controlled trial

The effect of low-dose esketamine on pain and post-partum depression after cesarean section: A prospective, randomized, double-blind clinical trial

Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study

The Efficacy of Low-Dose Esketamine and Butorphanol in Treating Depression and Pain After Cesarean Section

Effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis

Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial

Analgesic Effect of Esketamine Combined with Tramadol for Patient-Controlled Intravenous Analgesia After Cesarean Section: A Randomized Controlled Trial

Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial

Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study

Effect of esketamine on hypotension in women with preoperative anxiety undergoing elective cesarean section: a randomized, double-blind, controlled trial

Effect of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial

Intraoperative ketamine for reduction in postpartum depressive symptoms after cesarean delivery: A double-blind, randomized clinical trial

Patient-controlled intravenous administration of dexmedetomidine with nalbuphine versus sufentanil for post cesarean delivery analgesia: A retrospective observational study